Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
复制标题
DOI:
10.18632/oncotarget.16376
复制
发表时间:
2017-07-04
期刊:
影响因子:
--
通讯作者:
Bharti AK
中科院分区:
文献类型:
--
作者:
Ando K;Shah AK;Sachdev V;Kleinstiver BP;Taylor-Parker J;Welch MM;Hu Y;Salgia R;White FM;Parvin JD;Ozonoff A;Rameh LE;Joung JK;Bharti AK
Proteasomal degradation of topoisomerase I (topoI) is one of the most remarkable cellular phenomena observed in response to camptothecin (CPT). Importantly, the rate of topoI degradation is linked to CPT resistance. Formation of the topoI-DNA-CPT cleavable complex inhibits DNA re-ligation resulting in DNA-double strand break (DSB). The degradation of topoI marks the first step in the ubiquitin proteasome pathway (UPP) dependent DNA damage response (DDR). Here, we show that the Ku70/Ku80 heterodimer binds with topoI, and that the DNA-dependent protein kinase (DNA-PKcs) phosphorylates topoI on serine 10 (topoI-pS10), which is subsequently ubiquitinated by BRCA1. A higher basal level of topoI-pS10 ensures rapid topoI degradation leading to CPT resistance. Importantly, PTEN regulates DNA-PKcs kinase activity in this pathway and PTEN deletion ensures DNA-PKcs dependent higher topoI-pS10, rapid topoI degradation and CPT resistance.
登录
查看更多内容
影响因子:
0.9
作者:
Hsu FM;Zhang S;Chen BP
通讯作者:
Chen BP
影响因子:
8.8
作者:
Balestrini, Alessia;Ristic, Dejan;Petrini, John H. J.
通讯作者:
Petrini, John H. J.
影响因子:
4.8
作者:
Christensen, MO;Krokowski, RM;Mielke, C
通讯作者:
Mielke, C
影响因子:
2.9
作者:
KAISERMAN, HB;INGEBRITSEN, TS;BENBOW, RM
通讯作者:
BENBOW, RM
影响因子:
5.3
作者:
Douglas, Pauline;Zhong, Jianing;Lees-Miller, Susan P.
通讯作者:
Lees-Miller, Susan P.